Skip to content

Eli Lilly LLY Inventories

Inventories at other companies

Pfizer logo
PfizerPFE
$2.46B-11.9%
Amgen logo
AmgenAMGN
$6.19B-8.1%
Cardinal Health logo
Cardinal HealthCAH
$18.01B+11.4%
Mannkind logo
MannkindMNKD
$49.17M+70.2%
McKesson logo
McKessonMCK
$24.21B+5.2%
Exelixis logo
ExelixisEXEL
$63.91M-11.2%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.09T+56.4%
Enterprise value$1.12T+53.8%
P/E42.9×-7.3×
P/S15×+2.0×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:InventoryGross.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's inventories?
Eli Lilly (LLY) reported inventories of $14.49B in Q1 2026.
How has Eli Lilly's inventories changed year-over-year?
Eli Lilly's inventories increased by 56.1% year-over-year, from $9.28B to $14.49B.
What is the long-term trend for Eli Lilly's inventories?
Over 5 years (2020 to 2025), Eli Lilly's inventories has grown at a 28.0% compound annual growth rate (CAGR), from $3.98B to $13.7B.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.